Clinical Trials Browser

NETWORK × Interventional × blinatumomab × Clear all

NCT06237192 2024-02-01

MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult Patients

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma